INS and Alzheimer disease: To test this possibility, we selected young (3 months old) 3×Tg-AD animals at the beginning of the expression of molecular/neuropathological changes to test the effect DCI, which might help to prevent both insulin deficits and glutamatergic dysfunctions observed in old 3×Tg-AD mice.